Januvia Doesn’t Raise Heart Failure Risk

Results are in for people with type 2 diabetes who take the glucose-lowering drug sitagliptin (Januvia): In a three-year study of more than 14,000 people with heart disease, researchers found that the medication didn’t raise the risk of heart failure or other bad outcomes, such as heart attacks or strokes. In all, those events happened in about 11 percent of people, whether they were taking sitagliptin or a placebo. The findings are particularly reassuring after previous studies had suggested possible heart failure risk with another drug that works similarly to sitagliptin. Source:The New England Journal of Medicine, July 16, 2015